Ron Cohen

Title: The Innovations of Ron Cohen

Introduction

Ron Cohen is a notable inventor based in Irvington, NY (US), recognized for his contributions to the field of pharmaceuticals. With a total of six patents to his name, Cohen has made significant strides in developing innovative treatments for neurological diseases.

Latest Patents

Cohen's latest patents include groundbreaking methods of using sustained release aminopyridine compositions. One of his notable inventions is a pharmaceutical composition that comprises a therapeutically effective amount of aminopyridine dispersed in a release matrix. This composition can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet, which provides a therapeutically effective plasma level of aminopyridine for approximately 12 hours. This invention aims to treat various neurological diseases, including multiple sclerosis. Another patent focuses on a method of selecting individuals based on their responsiveness to treatment, specifically identifying those who respond to a sustained release fampridine composition. Additionally, he has developed a sustained release aminopyridine composition that can provide therapeutic effects for at least 12 hours, with the potential for 24 hours or more.

Career Highlights

Cohen is currently associated with Acorda Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that improve the quality of life for patients with neurological conditions.

Collaborations

Cohen has collaborated with notable colleagues, including Andrew R. Blight and Lawrence Marinucci, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ron Cohen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that address critical health challenges.